Boothbay Fund Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.78K | Hold |
13,378
| – | – | ﹤0.01% | 1207 |
|
|
2025
Q1 | $10.8K | Hold |
13,378
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q4 | $18.5K | Sell |
13,378
-6,840
| -34% | -$9.44K | ﹤0.01% | 1258 |
|
|
2024
Q3 | $21K | Hold |
20,218
| – | – | ﹤0.01% | 1351 |
|
|
2024
Q2 | $35K | Sell |
20,218
-1,046
| -5% | -$1.81K | ﹤0.01% | 1268 |
|
|
2024
Q1 | $50.8K | Sell |
21,264
-79,880
| -79% | -$191K | ﹤0.01% | 1292 |
|
|
2023
Q4 | $337K | Sell |
101,144
-96,222
| -49% | -$320K | 0.01% | 989 |
|
|
2023
Q3 | $738K | Buy |
197,366
+182,366
| +1,216% | +$682K | 0.02% | 739 |
|
|
2023
Q2 | $64.1K | Buy |
+15,000
| New | +$64.1K | ﹤0.01% | 1439 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 853 |
|
|
2020
Q1 | – | Sell |
-12,000
| Closed | -$216K | – | 777 |
|
|
2019
Q4 | $216K | Sell |
12,000
-20,747
| -63% | -$373K | 0.02% | 588 |
|
|
2019
Q3 | $663K | Sell |
32,747
-1,678
| -5% | -$34K | 0.06% | 337 |
|
|
2019
Q2 | $761K | Buy |
+34,425
| New | +$761K | 0.07% | 261 |
|